Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
Do you give lifelong anti fungal therapy or a set time period of anti fungal therapy to patients who have vertebral hardware infection with some residual hardware that cannot be removed?
Related Questions
Do you prefer a specific clinical scoring system to determine if a patient needs to be tested for Group A Streptococcal pharyngitis?
How do you manage a patient with suspected tick-borne encephalitis who has normal initial serological tests but continues to exhibit neurological symptoms in an endemic area?
Are you less likely to use cefiderocol for carbapenem-resistant Gram-negative bloodstream infections based on the GAME CHANGER trial showing non-inferiority to standard-of-care antibiotics?
How do you or your practice manage young, average-risk patients without structural lung disease referred to you or self-referred for concern of environmental mold exposure?
Do you routinely recommend D-mannose or probiotics for patients with recurrent urinary tract infections?
Do you approach suppressive antibiotic therapy differently for patients with cardiac implant- able electronic devices infections compared to patients with LVAD related infections?
How do you determine total duration of treatment for complicated GBS meningitis?
Do you treat complicated pneumonia with a drained empyema longer if Streptococcus anginosus is cultured, either in isolation or with other organisms, compared to cases in which it is not?
Would you use daptomycin to consolidate therapy in a patient with polymicrobial VRE and rothia bacteremia?
Do you avoid Daptomycin use when there is evidence of septic pulmonary emboli?
